Floatz logo

Pevonedistat

Polycythemia Vera

M.D. Anderson Cancer CenterPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Polycythemia Vera cohort.

Asset / SponsorPhaseRating
Ruxolitinib
University of Washington
Phase 4BB
Pegylated-Proline-Interferon Alpha-2B
AOP Orphan Pharmaceuticals AG
Phase 3BB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
Fludarabine
Thomas Jefferson University
Phase 2BB
Cyclophosphamide
Thomas Jefferson University
Phase 2BB

View all 36 →

Same molecule, other indications

Pevonedistat is also rated in:

chronic myelomonocytic leukemiaDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
66 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →